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Abstract
Macrophages play a crucial role in several diseases’ development and progression, such as in cancer and arthritis through 
ROS generation and inflammation. This makes macrophages a therapeutic target in these diseases. While silver nanoparticles 
(AgNP) have been widely used as an antibacterial and investigated as anticancer, its potential against macrophages may be 
limited due to its inherent oxidative mechanism. Here we encapsulated AgNP in a dipalmitoyl-phosphatidyl choline (DPPC) 
liposome (forming Lipo-AgNP) to suppress AgNP-induced ROS and enhance its cytotoxicity against THP1-differentiated 
macrophages (TDM). Our findings showed that while Lipo-AgNP had significantly more of a cytotoxic effect on TDMs 
(p < 0.01), it also significantly suppressed AgNP induced ROS generation and unexpectedly suppressed reduced glutathione 
(GSH) levels (p < 0.05) resulting in a redox imbalance in comparison to the unexposed control TDMs. Lipo-AgNP was also 
found to cause an increase DNA damage through H2AX histone phosphorylation and inhibition of Bcl-2 protein expres-
sion. This increased the Bax/Bcl2 ratio causing possible release of cytochrome C and subsequent caspase 3/7-dependent 
apoptosis. It was found that the difference between the mechanism of AgNP and Lipo-AgNP cytotoxicity may have been 
through the significantly increased Lipo-AgNP uptake by the TDMs as early as 30 min post-exposure (p < 0.05), changing the 
nanoparticle pharmacokinetic. In conclusion, the improved uptake of AgNP within the liposome caused ROS-independent 
caspase activation induced by Lipo-AgNP and this was facilitated by increased DNA damage, the induced redox imbalance 
and an increased Bax/Bcl-2 ratio.
Keywords Silver nanoparticle (AgNP) · Caspase 3/7 · Cell death · Apoptosis · Redox imbalance
Introduction
While macrophages are an essential component and are 
key players in the innate immune system, they also play 
a central role in maintenance of tissue homeostasis and 
developmental processes in defining physiological and 
pathological conditions. Due to this, macrophages have 
been widely studied as therapeutic target for diseases like 
rheumatoid arthritis, atherosclerosis and cancer as the 
role of this immune cell is known to be tilted to favour 
disease development under specific conditions, particu-
larly due to their induced inflammation [1]. The role of 
macrophages in cancer for instance involves the release 
of pro-inflammatory cytokines such as interleukin 1β (IL-
1β) and tumour necrosis-α (TNF-α) by tumour associated 
macrophages (TAM) within the tumour microenviron-
ment [2]. The release of these inflammatory cytokines like 
IL-1β can drive endothelial cell proliferation and secre-
tion of growth factors such as the vascular endothelial 
growth actor A (VEGF-A) by the endothelial cells, facili-
tating angiogenesis [3]. In the same manner, production 
of IL-1β and TNF-α aids recruitment of leukocytes that 
perpetuate inflammation, which facilitates proliferation 
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of synovial fibroblasts to form pannus that damages the 
rheumatoid arthritis joint [4]. It appears that the exagger-
ated inflammatory response of these macrophages may in 
part be facilitated by the high level of reactive oxygen spe-
cies (ROS) that is generated by the immune cell. There is 
evidence in the literature that macrophages generate a high 
level of ROS such super oxides and hydrogen peroxides 
within a tissue or organ even under minimal perturbation 
to the normal processes that may characterise a diseased 
condition [5, 6].
In support of this notion, ROS generation by macrophages 
have been documented to play key role in driving progres-
sion of atherosclerosis through NADH oxidase activity in 
production of RANTES (regulated on activation, normal 
T-cell expressed, and secreted), a chemokine that facilitates 
the homing of immune cells that boost inflammation within 
the atherosclerotic plaque [5, 7]. Macrophages-generated 
ROS also drives progression of cancer through secretion of 
TNF-α and IL-1β to drive hyperproliferation and arthritis 
through downregulation of regulatory T cells [8, 9]. Inter-
estingly, targeting ROS generated by macrophages has been 
shown to attenuate the development of atherosclerosis [10]. 
Likewise in cancer, liposomal bisphosphonates or monoclo-
nal antibodies have been employed to directly induce cyto-
toxic effect on TAMs to deplete the macrophages, preventing 
ROS generation or inflammation [1].
Silver nanoparticles (AgNP) are widely used as an anti-
bacterial in a variety of applications including wound treat-
ment and food preservation but have also been investigated 
as anticancer agent in recent years. AgNP has been shown to 
induce a cytotoxic effect on macrophages even at a very low 
dose [11] and may be effective in treating disease conditions 
mediated by macrophages as detailed above. Unfortunately, 
the main mechanism of AgNP action involves induction of 
ROS which effect myriad of intracellular responses such as 
DNA damage, increased Bax/Bcl-2 ratio, permeabilization 
of the mitochondrial membrane, degradation of key cellu-
lar protein and subsequent caspase 3/7-dependent apoptosis 
[12]. While the induction of caspase-dependent apoptosis 
may facilitate macrophage depletion within the atheroscle-
rotic plaque, a tumour microenvironment or the arthritic 
joint, the induced ROS may result in surge in secretion of 
inflammatory molecules by the macrophages themselves 
further favouring the disease condition.
We have previously shown that encapsulation of AgNP 
in a diphosphatidyl choline (DPPC) based liposome sup-
pressed AgNP-induced ROS generation in THP1 monocytes, 
enhanced the nanoparticle cytotoxicity in THP-1 monocytes 
[13] and suppressed AgNP-induced inflammation in THP-1 
monocytes and THP1 derived-macrophages [14]. This study 
investigated the cytotoxic effect of encapsulated AgNP 
(Lipo-AgNP) on THP-1 derived macrophages (TDMs) and 
further probed the mechanistic detail of the pathway utilised 
by Lipo-AgNP in inducing cell death, highlighting the diver-
gence to the pathway utilised by AgNP.
Experimental
Materials
Silver nitrate  (AgNO3) (CAS Number: 7761-88-8), sodium 
borohydride  (NaBH4) (CAS Number: 16940-66-2), dipalmi-
toyl phosphatidyl choline (DPPC) (CAS Number: 63-89-8), 
cholesterol (CAS Number: 57-88-5), Phorbol 12-myristate 
13-acetate (PMA) (CAS Number: 16561-29-8) and propid-
ium iodide (PI) (CAS Number: 25535-16-4), protease inhibi-
tor cocktail (Cat Number: P8340) were all purchased from 
Sigma Aldrich, Dublin Ireland. Chloroform (CAS Number: 
67-66-3) was from Fischer Scientific Dublin, Ireland while 
Calcein-AM dye (CAS Number: 1461-15-0),  H2DCFDA 
(Cat Number: D399) and Thiol Tracker™ (Cat Num-
ber: T10095) and Alamar blue (Cat Number: DAL1025) 
were all purchased from Biosciences LTD, Dublin Ire-
land. FIRELISA Human BCL-2 ELISA kit (Cat Number: 
ELISAFNHU00475) were all purchased from ELISAGenie, 
Dublin Ireland. Alexa  Fluor® 647 anti-H2AX Phospho (Ser-
139) antibody (Cat. Number: 613408) was purchased from 
Bio-legend through MSC, Dublin Ireland.
Methods
AgNP synthesis and encapsulation
To synthesise AgNP silver nitrate  (AgNO3) was chemically 
reduced sodium borohydride  (NaBH4) in a cold environment 
after which the resulting AgNP was encapsulated in lipo-
some made of dipalmitoyl-phosphatidyl choline (DPPC) and 
cholesterol forming Lipo-AgNP nanocapsules as described 
in our previous study, in addition to details of the charac-
terisation [13]. Briefly, 30 mL of 2 mM solution of  NaBH4 
was added to an Erlenmeyer flask placed in an ice bath and 
stirred at 350 rpm for 30 min to equilibrate after which 6 mL 
of 1 mM  AgNO3 was added to the  NaBH4 solution one drop 
per second under constant stirring. The stirring was stopped 
after all the  AgNO3 had been added, and the flask was taken 
out of the ice bath. To further prevent agglomeration of the 
AgNP the solution was placed back on the stirrer and stirred 
until room temperature (RT) was achieved. The resulting 
golden yellow solution was stable at 4 °C.
For encapsulation, dipalmitoyl phosphatidyl choline 
(DPPC) and cholesterol were dissolved in 5 mL chloroform 
and the solution was mixed until clear. It was then dried in a 
vacuum oven at 52 °C overnight (above melting temperature 
of DPPC). The resultant lipid cake was rehydrated in dis-
tilled deionised water  (ddH2O) at 60 °C in a shaker. After the 
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lipid was rehydrated, an AgNP solution was added to make a 
final lipid concentration of 1 mg/mL of DPPC and 0.23 mg/
mL of cholesterol to give a 7:3 molar ratio [15]. The solu-
tion was then placed in the shaker at 60 °C for another 20 
min after which it was vortexed briefly and extruded through 
a 100 nm Nanosizer polycarbonate extruder (TTScientific, 
Knoxville, USA). The resulting colloidal mixture was stored 
at 4 °C before use.
Scanning electron micrograph (SEM) and scanning 
transmission electron micrograph (STEM) analysis
SEM micrographs for free and encapsulated AgNP were 
obtained using a Hitachi SU-6600 field emission SEM 
(Hitachi, Maidenhead, UK) at an accelerating voltage of 25 
kV and working distance of 8 mm. For SEM analysis, a 5 
µL drop-cast of each sample was made onto a 5 × 5 mm pure 
silicon wafer substrate (Ted Pella Inc., Redding California, 
USA) 24 h prior to obtaining the micrographs and allowed to 
air dry. For STEM analysis, 3 µL of each sample was drop-
cast onto a carbon formvar copper grid (Agar Scientific Ltd., 
Stanstead, UK) 24 h prior obtaining and allowed to air dry.
Dynamic light scattering (DLS) analysis and zeta potential 
analysis
To measure the hydrodynamic diameter of the nanoparticle 
in solution, the DLS analysis of both AgNP and Lipo-AgNP 
was carried out with Malvern Zetasizer Nano ZS (Malvern 
Panalytical, Malvern, UK). The zeta potential measurement 
of the nanoparticles was also measured with Malvern Zeta-
sizer Nano ZS instrument set at 25 °C for all the samples. 
Nanoparticles were loaded into a pre-rinsed folded capillary 
cell up to the marked portion (usually filled with 1 ml of 
sample). An applied voltage of 15 and 50 V was used for 
Lipo-AgNP and uncoated AgNP respectively and a mini-
mum of three different measurements were made for each 
sample.
Cell culture and exposure
THP1 (ATCC ®: TIB-202™) cells were used in this study 
and were cultured in RPMI-1640 media supplemented with 
2 mM L-glutamine and 10% FBS. The cells were incubated 
at 37 °C, 95% humidity and 5%  CO2. For nanoparticle expo-
sure, cells were seeded in a 24-well plate (VWR, Dublin, 
Ireland) at a density of 3 × 105 cells/ml of culture media and 
1.5 ml of culture media per well. The cells were stimulated 
with 100 ng/ml (162 nM) PMA for 72 h THP1 differenti-
ated macrophages (TDM). The PMA containing media was 
then replaced with fresh RPMI media and the cells left to 
incubate for another 24 h [16].
For all cell exposure, the culture media on the cells were 
aspirated and the cells were rinsed in pre-warmed sterile 1× 
PBS solution. After this, the cells were incubated in RPMI 
media containing different concentration of either of AgNP 
or Lipo-AgNP ranging from 0.3 to 10 µg/ml. A negative 
control of unexposed cells was incorporated on the plate 
while a positive kill control of a 10% (v/v) dimethyl sul-
foxide (DMSO) solution and an internal positive control of 
 AgNO3 were o the plate.  AgNO3 was incorporated to assess 
the effect of Ag ionisation in AgNP on cell viability.
Cell viability
Cell viability of nanoparticle exposed TDMs was analysed 
by Alamar Blue assay (AB). A pre-warmed solution of 
AB (10% v/v) in serum free media was prepared and the 
exposure media on the TDMs were removed, after which 
the cells were rinsed with prewarmed sterile 1× phosphate 
buffer saline (PBS). Then, 1.5 ml of AB solution was added 
onto the cells and the plates were incubated at 37 °C for 2 h. 
The florescence of the converted AB dye was measured at 
540 nm excitation and 595 nm emission and wavelengths in 
a  SpectraMax® M3 Multi-Mode Microplate Reader.
Reactive oxygen species (ROS) assay
ROS generation in the THP1 differentiated macrophages 
consequent of particle exposure was monitored using 6-car-
boxy-2′,7′–dichlorofluorescin diacetate (carboxy-DCFDA) 
assay. This assay utilises esterase metabolism of carboxy-
DCFDA a non-fluorescent dye, into  H2DCFDA which 
is further oxidised to a green fluorescent DCFDA dye by 
ROS generated in the cell. To quantify the ROS genera-
tion, media on the TDMs seeded onto 24-well plate above 
were aspirated and replaced with RPMI media containing 
2% FBS. The cells were loaded with 10 µM of carboxy-
DCFDA dye and allowed to incubate for 30 min under above 
culture conditions. After this, the culture media containing 
carboxy-DCFDA were removed and the cells were rinsed 
in prewarmed sterile PBS. The cells were then incubated in 
media containing 2 µg/ml AgNP or Lipo-AgNP or 0.5 µg/
ml of  AgNO3 (as positive control) for specific time points 
to be analysed. Before ROS quantification, cells were rinsed 
once again in PBS and the media was replaced with PBS. 
ROS generation was then quantified by the fluorescence of 
the oxidised carboxy-DCFDA, by monitoring the dyes emis-
sion at 535 nm and 485 nm excitation on a Spectramax M3 
multiplate reader, using multi-well scan.
Reduced glutathione (GSH) assay
To measure the GSH levels, TDMs prepared as for ROS gen-
eration were exposed to both AgNP and Lipo-AgNP under 
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the same conditions as above for 4 h. After exposure, the 
cells were rinsed in prewarmed sterile PBS and incubated in 
RPMI media containing 10 µM of Thioltracker™ violet dye 
for another 30 min in the dark under incubation conditions 
used above. The cells were rinsed again in prewarmed sterile 
PBS after which they were covered in warm PBS. GSH level 
of in the cells were measured using Multi-well scan setting 
on a Spectramax M3 multiplate reader at 405 nm excitation 
and 530 emission wavelengths.
Flow cytometry
Flow cytometry analysis was used for both ROS generation 
and nanoparticle uptake. For ROS generation, TDMs already 
treated with carboxy-DCFDA were exposed to nanoparticles 
as above, rinsed in PBS and then gently scrapped off. The 
scrapped cells were resuspended in PBS containing 1% BSA 
and this method was subsequently used to detach the cells 
before analysis.
For nanoparticle uptake, RPMI media from TDMs cul-
tured as described above were aspirated and cells rinsed in 
PBS. The cells were then incubated in media containing 2 
µg/ml and the exposure media was removed at specific time 
points after which the cells were rinsed in PBS and detached 
as described above before flow cytometry analysis.
For live-dead staining, the TDMs were double stained by 
adding 5 µl of 1 µM calcein-AM stain and 10 µl of 10 µg/ml 
PI per 1 ml of RPMI media. The cells were then incubated 
in the dark at RT for 20 min after which they were detached 
by scrapping and processed as above for analysis by flow 
cytometry.
For γH2AX activation analysis, unexposed TDMs and 
TDMs exposed to 2 µg/ml AgNP and Lipo-AgNP and as a 
positive control, 0.5 µM of doxorubicin for 24 h after which 
the culture media on the cell was discarded. The cells were 
detached by gently scrapping off from the plate as described 
above and were washed in prewarmed sterile PBS followed 
by centrifugation at 300×g for 5 min to pellet the cells while 
the supernatant was discarded. The pellets were washed as 
before and then fixed in ice cold 70% (v/v) ethanol for alco-
hol fixation at − 20 °C for 2 h. The cell suspension was 
centrifuged at 500×g for 5 min to discard the ethanol, the 
cells washed as previously three times in flow buffer made 
up of PBS-BSA containing 0.1% sodium azide  (NaN3) using 
800×g centrifugation speed. The cells were permeabilised 
by resuspension in 0.25% PBS-Triton-X100 (PBS-T) for 5 
min at RT. PBS-T was completely removed by centrifugation 
at 400×g for 5 min as above. The cells were then blocked 
by resuspension in 2% (w/v) PBS-BSA and incubation at 
RT for 30 min.
To immunostain the cells with anti-H2AX antibody, 
the blocking solution was removed by centrifugation as 
described above. The cells were resuspended in flow buffer 
containing the antibody at 1:100 and incubated at 37 °C for 
30 min. The cells were washed to remove excess unbound 
antibodies as above using PBS. The cells were resuspended 
in fresh flow buffer solution analysed by flow cytometry in 
BD Accuri C6 flow cytometer.
Finally, for Caspase3/7 analysis, as before the TDMs were 
exposed to 2 µg/ml of either of AgNP or Lipo-AgNP for 24 
h. The cells were harvested as above and then resuspended 
in flow buffer of 1× PBS containing 0.1% sodium azide 
 (NaN3) and 1% BSA. The cells were then stained with 500 
nM CellEvent caspase 3/7 detection reagent and incubated 
at 37 °C for 30 min. After this, the cells were stained with 
1 µM SYTOX Advanced dead cell stain and incubated for 5 
min prior to being analysed by flow cytometry. All analyses 
were performed on a BD Accuri C6 flow cytometer.
Cell lysate collection and sandwiched enzyme linked 
immunosorbent assay (ELISA)
To collect cell lysate for protein expression analysis, culture 
media was aspirated from the cells after which the cells were 
rinsed in ice cold 1X PBS while the plate was kept on ice. 
The cells were lysed with 100 µl of RIPA buffer containing 
protease inhibitor cocktail per 3.5 × 105 cells and the cells 
were scrapped off and pipetted up and down gently to break 
up intact cell membranes. The lysate was transferred into a 
1.5 ml Eppendorf tube and centrifuged at 13,000×g for 10 
min at 4 °C. The supernatant was transferred into another 
1.5 ml Eppendorf tube and kept on ice to be analysed by 
ELISA. Sandwich ELISA of the collected lysate for Bax 
and Bcl-2 protein expression from TDMs exposed to AgNP 
or Lipo-AgNP was carried out following the manufacturer’s 
instructions. Absorbance was measured at 450 nm.
Statistical analysis
Statistical analysis was carried out using GraphPad Prism 
version 7. Data was analysed by Two-way analysis of vari-
ance (ANOVA) with Tukeys multiple comparison tests to 
detect significance in effects between exposure groups. Sta-
tistically significant differences in tests were indicated for 
p value < 0.05.
Results
Nanoparticle characterisation
Details of the characterisation of the AgNP and Lipo-
AgNP have been reported in our previous study [13]. In 
summary, the DLS analysis of both AgNP and Lipo-AgNP 
are shown in Table 1. below. As shown, the hydrodynamic 
radius of AgNP and Lipo-AgNP in  ddH2O were found to 
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be 20.47 nm and 139.0 nm respectively. Zeta potential 
measurements also depicted the Lipo-AgNP to be more 
stable with Zeta potential of −  30.8 mV compared with 
the free uncoated AgNP having zeta potential of −  25.7 
mV. In RPMI culture media, the mean particle size of 
AgNP increased to 79 nm likely due to interaction with 
the protein corona in the media while the size of the Lipo-
AgNP remained unaffected likely due to the protection of 
the liposome (Table 1). However, there was a significant 
drop in the zeta potential of both AgNP and Lipo-AgNP 
to − 7.90 mV and − 0.61 mV. This has been suggested 
to be due to the effect of the charged amino acid in the 
culture media protein [13]. The SEM of both AgNP and 
Lipo-AgNP indicated both nanoparticles to be of spherical 
morphology and in addition, the STEM showed the AgNP 
to be successfully encapsulated within the liposome of the 
Lipo-AgNP depicted as the grey area in the micrograph 
(Fig. 1a, b). The encapsulation was also confirmed by 
superposition of the DLS values of both AgNP and Lipo-
AgNP to observe any overlap of the Lipo-AgNP values 
with the AgNP values (Fig. 1c). Such overlap, if it occurs 
would have demonstrated incomplete and unsuccessful 
encapsulation of the AgNP. Interestingly the was no over-
lap of the values, further indicating successful encapsula-
tion. Estimation of the AgNP size from the SEM indicated 
a size of 14.3 ± 1.9 nm while Lipo-AgNP was estimated to 
82.73 ± 29.23 nm in size. The slight difference in the sizes 
may be due to the fact that DLS estimates the hydrody-
namic radius which is influenced by the dispersion media, 
in this case water, while the SEM shows the morphology 
of the nanoparticle in dry state.
Table 1  DLS analysis of both 
AgNP and Lipo-AgNP
AgNP Lipo-AgNP
In  H2O In RPMI In  H2O In RPMI
Size (nm) 20.47 ± 7.384 79.15 ± 66.67 139.0 ± 22.47 138.9 ± 54.93
PDI 0.186 0.566 0.127 0.421
Zeta (mV) − 25.7 − 7.90 − 30.8 − 0.61





























Fig. 1  Characterisation of AgNP and Lipo-AgNP by SEM/STEM and DLS a SEM with STEM (inset) of AgNP b SEM with STEM (inset) of 
Lipo-AgNP (black arrows indicating boundary of liposome c overlay of AgNP size value with Lipo-AgNP
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Macrophage cell viability
As stated, the cell viability of TDMs upon exposure to 
AgNP or Lipo-AgNP was evaluated by AB assay. The AB 
assay is routinely used to estimate cell viability based on 
the rate at which metabolically active cells reduce resa-
zurin, a non-fluorescent blue dye to resorufin, a pink 
fluorescent product. This chemical reduction of resazurin 
occurs in both the mitochondrion and the cytoplasm, thus 
it gives a broad indication of overall cellular viability [17]. 
TDMs were exposed to varying concentrations of AgNP, 
Lipo-AgNP and  AgNO3 (as positive control) ranging from 
0.3 µg/ml to 10 µg/ml. As shown in Fig. 2, the  AgNO3 used 
as a positive kill control for  Ag+ induced a significantly 
higher reduction in TDMs viability at all concentrations 
(p < 0.0001) with a 24 h  IC50 of 0.12 µg/ml. In comparison 
to AgNP induced reduction in cell viability at concentra-
tions ≤ 5.0 µg/ml while Lipo-AgNP induced significant 
reduction in TDMs viability at concentrations ≤ 2.5 µg/ml 
(p < 0.001) compared to control unexposed TDMs, mak-
ing Lipo-AgNP to have a lower  IC50 value compared to 
AgNP (3.98 µg/ml compared to 5.71 µg/ml respectively). 
In addition, Lipo-AgNP induced a significant reduction in 
TDM viability when compared with AgNP at 2.5 µg/ml. 
As a negative control, TDMs were also exposed to empty 
liposome at concentrations equivalent to the liposomes in 
2.5 and 5 µg/ml Lipo-AgNP. As shown in Supplementary 
Fig. 1, it was found that the empty liposomes did not affect 
the cell viability.
A calcein-AM/PI staining of TDMs was also carried 
out to confirm the result of the AB assay at a cellular level 
via an alternate technique. To evaluate cell viability here, 
2 µg/ml was chosen as a test concentration. This concen-
tration was just below that where a significant difference 
in both AgNP and Lipo-AgNP toxicity existed. Here the 
exposure of TDMs to Lipo-AgNP resulted in a significant 
reduction in TDM cell viability compared with control 
unexposed TDMs (p < 0.05), which was not observed for 
AgNP at the same concentration (Fig. 3). On the contrary, 
PI entry into the cells was similar in all groups. This was 
likely because the exposure concentration of the nanopar-
ticles was not toxic enough to cause cell death. To confirm 
if the liposome was not cytotoxic on the cell, manifesting 
as the observed cytotoxicity, the TDMs were exposed to 
an equal amount of empty liposome as contained in 2 µg/
ml Lipo-AgNP and it was found that the liposome did not 
affect the cell viability after 24 h exposure (Fig. 3).
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Fig. 2  Effect of AgNP, Lipo-AgNP and  AgNO3 on cell viability 
of TDMs. a TDMs were incubated with 0.3–10 µg/ml of either of 
AgNP, Lipo-AgNP or  AgNO3 for 24 h. Cells were incubated in 10% 
AB solution in 2% FBS-RPMI for another 2 h.  IC50 (24 h) was com-
puted for b AgNP c Lipo-AgNP and d  AgNO3. Data is represented as 
mean ± SD of 3 independent experiments. *** and **** are p < 0.001 
and 0.0001 respectively
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Lipo‑AgNP suppressed AgNP induced redox 
imbalance in TDMs
One of the known mechanisms of AgNP cytotoxicity respon-
sible for its antibacterial and anticancer properties is its abil-
ity to induce generation of ROS upon entry into the cell. As 
such we investigated whether the enhanced cytotoxic effect 
of Lipo-AgNP was due to its ability to enhance ROS gen-
eration. TDMs were exposed to either of 2 µg/ml of AgNP 
or Lipo-AgNP or 0.5 µg/ml of  AgNO3 as positive control 
after which the ROS generation upon exposure was ana-
lysed at different time points using flow cytometry (Fig. 4). 
A negative of the empty liposome at the same DPPC con-
centration as in 2 µg/ml Lipo-AgNP was also incorporated. 
As expected, AgNP exposure induced significantly higher 
generation of intracellular ROS at all time points investi-
gated when compared to the control unexposed and Lipo-
AgNP exposed TDMs. Although, percentage of cells that 
were positive for DCFDA fluorescence was comparable in 
all groups as shown in Fig. 4a, the MFI readings indicated 
that AgNP resulted in stronger intensity of ROS dependent 
DCFDA signals compared to other groups. ROS generation 
was highest for all groups at 1 h post exposure but this began 
to decline up until 4 hours. In contrast to AgNP, Lipo-AgNP 
exposure at all time points resulted in comparable levels 
of intracellular ROS generation with the unexposed control 
cells (Fig. 4b). The empty liposome was also found to induce 
comparable levels of ROS to the control untreated cells for 
all time points.
After demonstrating that Lipo-AgNP mediates a time 
dependent suppression of AgNP induced intracellular ROS, 
we investigated if this will be associated with the GSH lev-
els in the cells and thus the redox balance. This was done 
by exposing the TDMs to 1 µg/ml and 2 µg/ml of AgNP or 
Lipo-AgNP or empty liposome at the same DPPC concen-












































Fig. 3  Calcein/PI staining of TDMs exposed to AgNP and Lipo-
AgNP. TDMs were exposed to 2 µg/ml of AgNP or Lipo-AgNP or 
0.5 µM of Dox or empty liposome containing DPPC and cholesterol 
as in 2 µg/ml Lipo-AgNP for 24 h before staining with 1 µM calcein-
AM and 10 µg/ml PI stain for 20 min. Conversion of Calcein-AM to 
fluorescent calcein was measured by detecting the dye MFI in FL-2 
channel while PI entry into the cell was detected in the FL-4 of a BD 
Accuri 6 cytometer. Data is represented as mean ± SD of three inde-
pendent experiments. MFI was calculated from intensity of 50 indi-
vidual cells per experiment. ** is p < 0.01
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glutathione (GSH) levels were then quantified by spectro-
photometry. As observed previously, 2 µg/ml Lipo-AgNP 
suppressed AgNP-induced ROS generation and in the same 
manner contrary to what was expected (Fig. 5a), Lipo-AgNP 
also significantly reduced the level of GSH in the TDMs 
compared to both AgNP exposed and control unexposed 
TDMs (p < 0.05) (Fig. 5b). As also observed in the confocal 
microscopy result, the empty liposome induced comparable 
levels of ROS and GSH as in the control untreated groups 
(Supplementary Fig. 2). This observation is indicative of a 
redox imbalance due to Lipo-AgNP exposure as a high GSH 
level is expected due to ROS suppression and that the empty 
liposome is relatively non-toxic to the cells.
Caspase 3/7 pathway activation
ROS is one of the major upstream factors in the caspase 
3/7 apoptotic pathway, and indeed the main mechanism of 
AgNP induced apoptosis. The above data demonstrated that 
Lipo-AgNP induced a higher cytotoxic effect on TDMs com-
pared to AgNP, which is independent of intracellular ROS 
generation and was accompanied by reduced GSH levels. It 
has been previously shown that this redox imbalance cre-
ated by suppressed ROS and GSH levels induced caspase 
3-dependent apoptosis [18]. Based on this, we initially 
probed activation of caspase 3/7 upon exposure of the TDMs 
to 2 µg/ml AgNP or Lipo-AgNP. It was found that AgNP 
induced significant activation of caspase 3/7 at 24 h com-
pared to the unexposed (p < 0.0001) which was similar to 
that induced by Lipo-AgNP (Fig. 6). However, exposure of 
the TDMs to AgNP and the observed caspase 3/7 activation 
did not translate to observable cell death as indicated by flu-
orescence due to the Sytox AAdvanced stain for dead cells. 
Contrary to this, Lipo-AgNP exposure resulted to significant 
number of dead cells after 24 h despite inducing activation 
of caspase 3/7 at similar level with AgNP (p < 0.001).
Bax and Bcl-2 are respectively pro- and anti-apoptotic 
factors in the intrinsic cell death pathway that act upstream 

























































































































Fig. 4  ROS generation by TDMs pot-exposure to AgNP and Lipo-
AgNP. TDMs were preloaded with 10 µM  H2DCFDA for 30 min 
before exposure to 2 µM AgNP or Lipo-AgNP or 0.5 µg/ml  AgNO3 
or empty liposome containing DPPC and cholesterol as in 2 µg/ml 
Lipo-AgNP for up to 4 h. a Plot of percentage of cell population with 
positive DCFDA fluorescence b plot of the MFI of TDMs. Statisti-
cal significance was analysed by One-way ANOVA Turkeys multiple 
comparison tests for each time point. Data represents mean ± SD of 3 
independent experiments. * p < 0.05 and ** p < 0.01
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of caspase 3/7. We next probed the protein expression of 
Bax and Bcl-2 after AgNP and Lipo-AgNP exposure. TDMs 
were exposed to 2 µg/ml of AgNP or Lipo-AgNP for 24 h 
after which cell lysate was obtained from the cells. Immu-
noassay of the lysate indicated that none of the nanoparti-
cles influenced Bax protein expression when compared with 
Bax expression in control unexposed group (Fig. 7a). On 
the other hand, Lipo-AgNP exposure was found to signifi-
cantly inhibit Bcl-2 protein expression (p < 0.001). Bax to 
Bcl-2 ratio (Bax/Bcl-2) is widely used as an indicator of 
apoptotic status of a cell [19]. Bax/Bcl-2 analysis carried 
out showed that Lipo-AgNP exposure exhibited the highest 
ratio compared to AgNP exposure or non-exposure of the 
control group (p < 0.05), explaining the observed cell death 
upon exposure to Lipo-AgNP.
siRNA of Bcl-2 has been demonstrated to make cancer 
cells sensitive to DNA damage resulting in apoptosis [20]. 
Based on this we investigated if Lipo-AgNP could be caus-
ing DNA damage which in addition to the low Bcl-2 expres-
sion might be the reason for the observed apoptosis. Activa-
tion of H2AX was evaluated in TDMs 24 h post exposure to 
AgNP or Lipo-AgNP. This is because formation of H2AX 
foci upon phosphorylation signals increased DNA double 
strand break (DSB). A significant activation of γH2AX 
was observed in cells exposed to Lipo-AgNP while AgNP 
exposed TDMs showed comparable γH2AX fluorescence 
with control unexposed TDMs (Fig. 7b). Thus, Lipo-AgNP 
induced DNA damage in the TDMs which may have resulted 
in apoptosis due to low Bcl-2 expression in the cells.
Effect of liposomal encapsulation on AgNP uptake
A time dependent intracellular ROS generation in the TDMs 
indicated that ROS generation was highest for all exposure 
groups at 1 h after which the level dropped considerably. 
This indicates that the AgNP and Lipo-AgNP must have 
been internalised by the cells prior to 1 h time point. As 
such, we investigated the time course uptake of the nanopar-
ticles by flow cytometry since the nanoparticles will increase 
the internal complexity of the cell, which can be accurately 
monitored by the SSC values. The uptake studies indicated 
that Lipo-AgNP was significantly internalised by the TDMs 
at 30 min (p < 0.01) while the AgNP was not internalised at 
this time point since AgNP exposed TDMs had comparable 
SSC value when compared with the control unexposed cells 
(Fig. 8). At 45 min, AgNP and Lipo-AgNP uptake had sig-
nificantly increased (p < 0.0001) but Lipo-AgNP uptake was 
significantly higher than that of AgNP (p < 0.0001). At 1 h 
post exposure to the nanoparticles, there was an observed 
drop in the SSC values of the TDMs which was likely due 
to the degradation of the nanoparticles. This continued up 
till 24 h when none of the nanoparticles seem to be in the 
cells based on the comparable SSC values with control unex-
posed cells. This finding indicates that entry of the silver 
nanoparticle at 45 min must have resulted in ionisation of 
the nanoparticle causing increased intracellular ROS levels, 
which may have been suppressed by the liposome shell of 
Lipo-AgNP.
Discussion
We recently showed in THP-1 monocytes that AgNP encap-
sulation in liposome enhances the nanoparticle cytotoxic-
ity through steady release of AgNP and induced a cas-
























































































Fig. 5  Redox balance in AgNP and Lipo-AgNP exposed cells. a 
Cells were treated as previously for ROS and the ROS level in cells 
at 1 h post exposure to 2 µM of AgNP and Lipo-AgNP and 0.5 µg/
ml  AgNO3 or empty liposome containing DPPC and cholesterol as 
in 2 µg/ml Lipo-AgNP was measured spetrophotometrically b GSH 
levels as measured in TDMs by first exposing the cells to 2 µM 
AgNP or Lipo-AgNP or 0.5 µg/ml  AgNO3 or empty liposome con-
taining DPPC and cholesterol as in 2 µg/ml Lipo-AgNP for 1 h and 
then to Thioltracker™ for 30 min before measurement. Statistical sig-
nificance was analysed by Two-way ANOVA Tukeys test. Data rep-
resent mean ± SD of 3 independent experiments. * p < 0.05 and *** 
p < 0.001
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monocytes [13, 14]. Based on the different roles of mono-
cytes and macrophages in disease development as well as 
their varying responses to different stimuli, this study was 
carried out to probe the molecular mechanism utilised by 
Lipo-AgNP in inducing cell killing effect in TDMs. As pre-
viously observed for THP-1 monocytes, Lipo-AgNP also 
demonstrated higher cytotoxicity on the TDMs compared 
with AgNP. However, the  IC50 for Lipo-AgNP in the TDMs 
was slightly higher than what we previously recorded for 
the monocytes. This may be due to the higher uptake rate of 
the nanoparticle by TDMs because of their active phagocy-
tosis compared to THP-1 monocytes, coupled with a more 
sensitive nature of monocytes. Beduneau et al. [21] have 
previously demonstrated that macrophages exhibit higher 
uptake rate of IgG coated and uncoated super-magnetic iron-
oxide nanoparticles compared to monocytes, although the 
study showed the nanoparticle exhibited similar toxicity in 
both THP-1 and TDMs which was only after 1 h of expo-
sure. A longer time point might have shown the nanoparticle 
is more toxic in TDMs. In support of this, Wu et al. [22] 
demonstrated the SPIONs induced release of pro-inflam-
matory cytokines after 24 h exposure of macrophages to the 
nanoparticles.
ROS generation has been documented to be the main 
mechanism utilised by AgNP to induce apoptosis in differ-
ent cell types. Entry of AgNP into the cytoplasm results 
in ionisation of the nanoparticle by the aqueous environ-
ment into silver ions, which subsequently causes genera-
tion of intracellular ROS that oxidise cellular proteins and 
subcellular structures like the mitochondria or induce DNA 
damage, culminating in caspase-dependent apoptosis [23]. 
Interestingly, the role of macrophages in diseases such as 
cancer and atherosclerosis are largely modulated on the 
ability of the immune cell to generate or respond to high 
intracellular ROS within the tumour microenvironment to 
suppress anticancer immune response or the atherosclerotic 
plaque to induce expression of adhesive molecules that 

















































Fig. 6  Activation of caspase 3/7 and induction of apoptosis by AgNP 
and Lipo-AgNP. TDMs exposed to 2 µg/ml AgNP or Lipo-ANP or 
0.5 µM Dox or empty liposome containing DPPC and cholesterol as 
in 2 µg/ml Lipo-AgNP for 24 h were stained with 500 µM of CellEv-
ent and 1 µM of SytoxAADvanced stain as describe in methods. The 
fluorescence obtained from confocal microscopy (left) was converted 
into digital data (right) using imageJ software. Statistical significance 
was computed using Two-way ANOVA with Tukeys multiple com-
parison test. Data repesents mean ± SD of three independent experi-
mental repeats and ***p < 0.001 and ****p < 0.0001
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this study to investigate Lipo-AgNP effectiveness on mac-
rophages that may be within the tumour microenvironment, 
especially since Lipo-AgNP possess an anti-inflammatory 
property in these cells [14]. As expected AgNP exposure 
of TDMs resulted in ROS generation supporting findings of 
other studies [11, 25]. Contrary to this and as we have previ-
ously shown in THP-1 monocytes, Lipo-AgNP suppressed 
AgNP induced intracellular ROS generation. This indicates 
that the encapsulation prevented or delayed the ionisation 
of the coated AgNP which does not explain the enhanced 
cytotoxicity.
Increased ROS generation is often coupled with reduction 
in level of GSH. GSH is a tripeptide of glutamine, cysteine 
and glycine, a biologically active antioxidant against the 
activities of ROS. Oxidation of GSH by increasing level of 
ROS results in crosslinking of the two molecules of oxidised 
glutathione to GSSG causing a drop in the level of GSH and 
vice versa under low ROS levels. As expected, we found that 
exposure to AgNP resulted in reduced GSH level. AgNP is 
known to induce ROS generation, GSH depletion and activa-
tion of caspase 3 [26]. Interestingly, Lipo-AgNP exposure 
also resulted in reduced GSH levels which was unexpected 
since the encapsulation prevented AgNP-induced ROS. The 
reason for this is currently unknown but this redox imbal-
ance has been previously demonstrated to induce activation 
of caspase 3/7 dependent apoptotic pathway [18]. It is pos-
sible suppression of GSH by Lipo-AgNP is coupled with 
activity of Bcl-2 since we observed inhibition of Bcl-2 pro-
tein expression. A previous study showed that Bcl-2 over-
expressing human leukaemia cells have high level of GSH, 
and another showed that the overexpression of Bcl-2 in a 
lymphoma cell line aids intranuclear sequestration of GSH 
[27, 28], which may inhibit ROS induced activation of cas-
pase 3/7.
Increased expression and activation of Bax causes 
destabilisation of mitochondrial outer membrane result-
ing in release of cytochrome C, activating downstream 
factors preceding activation of caspase 3 and 7. Bcl-2 as an 
Fig. 7  Bax/Bcl-2 ratio and DNA damage in AgNP and Lipo-AgNP 
exposed TDMs. a Lysates from TDMs exposed to 2 µg/ml of AgNP 
or Lipo-AgNP or 0.5 µM of Dox or empty liposome containing DPPC 
and cholesterol as in 2 µg/ml Lipo-AgNP for 24 h were collected 
and immunoprobed by ELISA for Bax and Bcl-2 and the Bax/Bcl-2 
ratios were computed b TDMs exposed as above were incubated in 
anti-phosphoH2AX antibody as described in methods and the H2AX 
phosphorylation was analysed by flow cytometry. Statistical signifi-
cance was carried out by One-way ANOVA with Dunnet’s multiple 
comparison test. Data is represented as mean ± SD for n = 3 independ-
ent experimental repeats
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anti-apoptotic factor binds Bax to prevent mitochondrial 
dysfunction. However, an increased Bax expression rela-
tive to a low Bcl-2 expression results in a high Bax/Bcl2 
ratio causing Bax to induce mitochondrial outer membrane 
permeabilization (MOMP), with release of cytochrome C 
and a subsequent activation of caspases 3 and 7 down in 
the intrinsic apoptotic pathway [29, 30]. As such, the Bax/
Bcl-2 ratio has been used as a prognostic factor for sur-
vival in different cancers and even as predictor of cancer 
cells response to chemotherapy [31–33]. Interestingly, it 
has been demonstrated that AgNP induces expression of 
Bax increasing Bax/Bcl-2 ratio to induce apoptotic cell 
death in male Wistar rats [34].
Based on the above and to establish a link between Bcl-2 
expression and the low GSH level observed in Lipo-AgNP 
exposed TDMs, we investigated for their Bax and Bcl-2 
expression in response to AgNP and Lipo-AgNP expo-
sure. Bax protein levels was unaffected in all the exposure 
groups but Lipo-AgNP was found result in suppression Bcl-2 
protein expression. This kept the Bax/Bcl-2 ratio high for 
Lipo-AgNP exposed TDMs. A high Bax/Bcl-2 ratio has been 
reported to be associated with increased apoptosis in cells 
due to high Bax expression and a relatively unaffected Bcl-2 
expression in cells exposed to therapeutic agent relative to 
control cell lines [19]. Although this contradicts our find-
ing here where the Bax level is similar in all exposure and 
control groups, the low Bcl-2 level kept the Bax/Bcl2 lev-
els high such that there is enough free Bax that will induce 
mitochondria dysfunction and caspase 3/7 activation in 
Lipo-AgNP exposed TDMs.
We previously showed that Lipo-AgNP induced DNA 
fragmentation and cell cycle arrest at the S-phase of THP1 
monocytes [13]. This is likely because cells with fragmented 
DNA cannot successfully proceed through the S-phase due 
to replication failure. We further confirmed here that Lipo-
AgNP induced DNA damage as the exposure of TDMs to the 
nanoparticle resulted in significant γH2AX activation. Phos-
phorylation of H2AX histone result in formation of γH2AX, 
which recruits DNA damage repair proteins, hence its use 
as a marker of DNA damage. Bcl-2 overexpression has also 
been shown to suppress DNA repair, allowing cancer cells 
accumulate mutations which result in genome instability, a 
hallmark of cancer [35]. Deng et al. [36] also demonstrated 
that Bcl-2 accelerates recovery of prostate cancer cells from 
oxidative stress induced nuclear and mitochondrial DNA 
damage. Taken together, Lipo-AgNP may have induced 
DNA fragmentation causing H2AX phosphorylation and 
the low level of Bcl-2 could not allow for Bcl-2 mediated 
survival of the cell, further making the cells more sensitive 
to the cytotoxic effect of Lipo-AgNP just as high Bax/Bcl-2 
ratio is known to sensitize cancer cells to chemotherapeu-
tic agents [33]. This coupled with the high Bax/Bcl-2 ratio 
could synergistically induce activation of caspase-dependent 
apoptotic pathway.
We have shown here that Lipo-AgNP is more cytotoxic 
than AgNP, inducing a caspase-dependent apoptosis. While 
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Fig. 8  Nanoparticle uptake by TDMs. TDMs were exposed to 2 µg/
ml AgNP or Lipo-AgNP for 24 h after which cells were rinsed and 
analysed by flow cytometry. Statistical analyses were carried out by 
One-way ANOVA with Dunnet’s multiple comparison test. Data 
is represented as mean ± SD for n =  three dependent experimental 
repeats
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AgNP was found to be less cytotoxic than the Lipo-AgNP, 
the uncoated nanoparticle also induced a caspase-dependent 
apoptosis which was dependent on intracellular ROS genera-
tion. This differing mechanism for Lipo-AgNP and AgNP 
led to our hypothesis that Lipo-AgNP must have a distinct 
pharmacokinetic mechanism when compared with AgNP. 
In essence, these nanoparticles must have been metabolised 
in different ways once they are internalised by the cells. To 
test this, we monitored the uptake of both AgNP and Lipo-
AgNP by evaluating the SSC values of the cells at specific 
time point. Generally, the SSC value of cells increases with 
particle uptake due to increase in their internal complexity 
and there are studies that have successfully applied this tech-
nique to measure nanoparticle uptake [37–39]. Measuring 
the SSC has several advantages. Firstly, in comparison with 
fluorescently probing particle uptake, loss of fluorescent 
intensity will affect the result of particle uptake since SSC 
measurement does not require cell staining. Secondly, this 
method is also more valuable in comparison with cell lysis 
as particles can react with lysis reagent which may confound 
data from subsequent quantification. Finally, this method 
is cheap and fast. Measurement of Lipo-AgNP and AgNP 
uptake showed that Lipo-AgNP was significantly internal-
ised after 30 min of exposure. AgNP internalisation was not 
observed until after 45 min of exposure, which confirms the 
encapsulation of AgNP in liposome resulted in increased and 
faster uptake of the nanoparticle. This finding is supported 
by findings in different studies that reported that liposome 
encapsulation of pharmacologically active agents enhances 
drug uptake and delivery, producing better toxicity profile 
and increased bioavailability [40–42].
Combining the uptake data with the ROS studies, while 
Lipo-AgNP were already internalised at 30 min, it did not 
result in any rise in intracellular ROS which indicates that 
the encapsulated AgNP had not been exposed to the aque-





















Fig. 9  Proposed mechanism of action of Lipo-AgNP
Lipo-AgNP is endocytosed and within the endosome the liposome 
protects the AgNP from ionisation in the cytosol. The AgNP is 
released likely close to the nucleus where it easily undergoes nuclear 
translocation to cause DNA fragmentation. Prevention of ROS gen-
eration and suppression of GSH level result in redox imbalance that 
in addition to Bcl-2 inhibition and Bax induction of MOMP causes 
caspase 3 and 7 activation
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correlation with AgNP uptake by the TDMs, significant 
intracellular ROS generation was observed at 1 h which was 
after 15 min of detected uptake and while the ROS level 
dropped afterwards, it was still significantly higher than that 
of other cell groups. While the ROS generated by AgNP 
would have been responsible for the cytotoxicity observed 
in AgNP-exposed TDM, the ROS level was likely not high 
enough to suppress Bcl-2 expression or DNA damage. This 
also explains why the cell killing effect of AgNP as depicted 
by Sytox AADvanced staining was significantly less in 
AgNP-exposed TDMs when compared with Lipo-AgNP 
exposed cells (Fig. 6). In addition, the caspase activation 
induced by Lipo-AgNP must have occurred earlier than that 
of the AgNP due to the improved uptake causing cell death 
earlier than in AgNP-exposed TDMs. This may be the reason 
why caspase activation was comparable between AgNP and 
Lipo-AgNP at 24 h but AgNP cell killing effect may occur 
long after Lipo-AgNP. This is an indication of slower kinet-
ics of AgNP mechanism compared with Lipo-AgNP. On the 
contrary, Lipo-AgNP maintained comparable intracellular 
ROS levels as the control unexposed TDMs indicating ROS 
was not involved in its mechanism. Taken together, it seems 
the interaction between the lipid bilayer of the liposome 
and that of the TDMs facilitated uptake of the liposome. 
However, entry of the liposome prevented ionisation of the 
AgNP allowing direct nuclear delivery of the nanoparticle 
at concentrations high enough to cause DNA damage which 
resulted in phosphorylation of H2AX and suppression of 
Bcl-2 expression. The low level of Bcl-2 in the cells did 
not match Bax levels allowing free Bax to bind to the mito-
chondrial membrane causing MOMP and possible release 
of cytochrome C and subsequent activation of caspase 3/7 
to induce apoptosis (Fig. 9).
Conclusion
AgNP main mechanism of inducing apoptosis has been 
reported in different studies to involve generation of ROS 
and offset of the Bax/Bcl-2 ratio causing MOMP. Here we 
confirmed that low dose AgNP induce significant generation 
of intracellular ROS coupled with depletion of GSH but the 
no significant cell death. ROS generation and inflammation 
are tightly coupled, and this may be responsible for AgNP-
induced associated inflammation reported in previous stud-
ies. On the contrary, we showed that Lipo-AgNP suppressed 
ROS generation but depleted GSH level creating a redox 
imbalance. This redox imbalance and DNA damage caused 
by Lipo-AgNP may be responsible for the suppression of 
Bcl-2 increasing the Bax/Bcl-2 ratio to facilitate effective 
MOMP that may have induced observed caspase 3/7 activa-
tion and then cell death.
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